Thread by @GeorgePeretzQC

Good piece illustrating the trade-offs involved in getting rid of retained EU law in the shape of complex regulatory regimes. 2 points.

https://twitter.com/samuelmarclowe/status/1491534832429633545

1. These are really important and difficult policy choices. These should be made by primary legislation, scrutinised by Parliament, with those affected given a chance to be heard. Not by barely-scrutinised flicks of a Minister’s pen.

2. One other problem with the unilateral “we’ll let in products approved by countries we trust” options floated by Sam is loss of U.K. regulatory capacity and accountability. That matters when things go wrong: which, in this area, they can - very badly. Remember breast implants.

PS - this is an area where Ministers can, already, replace the retained regime inherited from the EU at will (Medicines and Medical Devices Act 2021). So far, hardly any changes.